NEW ORLEANS — Since a report in 2014 of two patients with severe bilateral ischemic retinal vasculitis following cataract surgery, attention has centered on the phenomenon of hemorrhagic occlusive retinal vasculitis in which intracameral vancomycin is the presumed etiological agent.
In 2016, a joint task force of the American Society of Cataract and Refractive Surgery and the American Society of Retina Specialists identified 36 eyes of 23 patients who had received vancomycin during cataract surgery and developed hemorrhagic occlusive retinal vasculitis (HORV), prompting a clinical alert
Uncategorized